Skip to main content

Table 1 Patient characteristics, N = 31

From: Recurrence pattern analysis after re-irradiation with bevacizumab in recurrent malignant glioma patients

Characteristic

Patients

Sex

 

  • Male

21 (67.7%)

  • Female

10 (32.3%)

Median Age [y]

51.0 (18 – 67)

Median KPS

80 (40 – 100)

  • KPS < 70

8 (25.8%)

  • KPS ≥ 70

23 (74.2%)

Median dose of primary radiotherapy

60 Gy

Median dose of re-irradiation

36 Gy

Median PTV size [ml]

118.1 (34.3 – 363.9)

MGMT methylation status

 

  • methylated

11 (35.5%)

  • not methylated

18 (58.1%)

  • unknown

2 (6.5%)

WHO grade at relapse

 

  • III

6 (19.4%)

  • IV

25 (80.6%)

Recurrence pattern

 

  • in-field

19 (61.3%)

  • marginal

7 (22.6%)

  • distant

5 (16.1%)

Imaging type for recurrence

 

  • MRI/CT

10 (32.3%)

  • PET

21 (67.7%)